However, ASIC inhibitors appear effective in preventing EMT and cancer or HCC cells migration by altering the acidic extracellular pH (Jin et al., 2015) but are not likely to massively affect intracellular sodium concentration and are not reported to inhibit cancer growth. The gene discussed is ASIC1; the disease is hepatocellular carcinoma.